Clean Science & Technology Ltd. · NSE:CLEAN
Clean Science & Technology — Q4 FY2022 Earnings Presentation
17 slides from Clean Science & Technology's earnings presentation, May 28, 2022
Slide 1: Cover letter to stock exchanges: Investor Presentation
Clean Science and Technology Limited innovotion otwork Date:28.05.2022 To, BSE Limited National Stock Exchange of India Limited Phiroze JeeJeebhoy Towers, Exchange Plaza, Plot no. C/1, Dalal Street, G Block, Bandra-Kurla Complex Fort, Mumbai - 400 001 Bandra (E), Scrip Code: 543318 Mumbai - 400 051
Slide 2: Q4 & FY 2022 Results Presentation
Q4 & FY 2022 RESULTS PRESENTATION May 2022
Slide 3: Updates for Quarter 4 and FY2022
UPDATES FOR QUARTER 4 AND FY2022
Slide 4: Summarizing FY 2022 Performance
SUMMARIZING FY 2022 PERFORMANCE Meaningful revenue growth continues, inflationary headwind persists • Recorded highest ever revenue for a financial year; sequential growth in revenues for 5th quarter now Mixed quarter • Margins impacted due to record prices of key inputs Key Input prices (INR/Kg) Re
Slide 5: P&L Overview – Meaningful Revenue Growth
P&L OVERVIEW – MEANINGFUL REVENUE GROWTH Benefits of operating leverage did not crystallize majorly due to steep increase in input prices Particulars Q4 Q3 Q-o-Q Q4 Y-o-Y Y-o-Y FY 2022 FY 2021 (INR Crore) FY 2022 FY 2022 (%) FY 2021 (%) (%) Revenue from product sales 202.9 178.2 14% 132.4 53% 677.5
Slide 6: Balance Sheet Summary
BALANCE SHEET SUMMARY Return ratios impacted due to subdued margins and sizeable capex, which is yet to reach optimal utilization In INR Crore As at 31 March 2022 As at 31 March 2021 Assets Fixed Assets 292.3 182.6 Capital work-in-progress 44.1 55.0 Right of use asset 2.9 3.0 Other non-current asset
Slide 7: Sales Profile – FY 2022
SALES PROFILE – FY 2022 Strong sales growth across all segments and all geographies 139.0 Revenue mix by segment Revenue mix by geography 115.1 90.0 FY 2022 FY 2021 35.7 36.3 6% 6% 25.6 24.5 23.1 14.7 12% 14% Performance Chemicals Pharma Chemicals FMCG Chemicals 14% 15% 472.7 Q4 FY22 Q3 FY22 Q4 FY21
Slide 8: Corporate Presentation
CORPORATE PRESENTATION
Slide 9: Company Evolution
COMPANY EVOLUTION Focus on R&D and innovation has led to new product launches on a consistent basis • In line with our vision, • Started manufacturing • Started • Started • Started changed name to Anisole using liquid manufacturing manufacturing manufacturing DCC Clean Science and phase technology p
Slide 10: Key Differentiators
KEY DIFFERENTIATORS Helped company develop into a global supplier of critical specialty chemicals in just 15 years Among the largest Multiple, automated Unique, innovative, producers globally of manufacturing facilities sustainable and cost- critical specialty with zero liquid discharge effective ca
Slide 11: Strong In-house R&D
STRONG IN-HOUSE R&D Pioneered commercialization of catalytic-reactions in production processes • Designing catalysts to create novel manufacturing processes R&D • Develop eco-friendly processes by optimizing use of toxic starting materials Strategy • Focus on enhanced atom economy to minimize wastag
Slide 12: Technocrat Promoters
TECHNOCRAT PROMOTERS Promoters’ sole business interest remains Clean Science and Technology with 78.51% stake Ashok Boob Over 26 years of work experience in the chemical industry. Managing Director B.Chem. Engg. - ICT, Previously worked as an Executive Director at Mangalam Drugs Mumbai, India Key fu
Slide 13: Robust Corporate Governance
ROBUST CORPORATE GOVERNANCE Distinguished Board of Directors and reputed financial market reviewers Pradeep Rathi Prof. G. D. Yadav Sanjay Kothari Chairman and Non-Executive Director Non-Executive, Non-Executive, Independent Director Non-Independent Director B.Sc, M.S. (MIT, USA), MBA (Columbia, USA
Slide 14: Diversified Product Profile
DIVERSIFIED PRODUCT PROFILE De-risked business model with product applications across various critical end-user industries PRODUCT APPLICATION REVENUE (INR Crore) PERFORMANCE CHEMICALS 473 • Polymerization inhibitor in acrylic acids, acrylic esters, super MEHQ (Monomethyl ether of 355 absorbent po
Slide 15: Strong Financials
STRONG FINANCIALS Resilient performance demonstrated over business cycles REVENUE EBITDA & EBITDA% PAT & PAT% CAGR of 30% EBITDA CAGR of 42% PAT CAGR of 47% 685 400 51% 60% 250 50% 44% 44% 39% 50% 200 33% 33% 40% 512 300 35% 419 30% 40% 25% 393 150 20% 30% 200 30% 243 100 229 20% 300 20% 198 259 140
Slide 16: Commitment Towards ESG
COMMITMENT TOWARDS ESG ENVIRONMENT (E) SOCIAL (S) CORPORATE GOVERNANCE (G) Awarded the “Greenco Silver” rating by Total contribution towards CSR activities More than 1/3rd Board members are GreenCo - Green Company Rating System. during last 3 years is INR 10.5 crore independent First specialty
Slide 17: Disclaimer
DISCLAIMER Certain statements and opinions with respect to the anticipated future performance of the company in the presentation (“forward - looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Such
Clean Science and Technology — Q4 FY2022 Earnings Presentation on 6ix